Filing Details
- Accession Number:
- 0001209191-15-066416
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-08-17 20:00:34
- Reporting Period:
- 2015-08-13
- Filing Date:
- 2015-08-17
- Accepted Time:
- 2015-08-17 20:00:34
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1411158 | Anacor Pharmaceuticals Inc. | ANAC | Pharmaceutical Preparations (2834) | 251854385 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1202769 | L Paul Berns | C/O Anacor Pharmaceuticals, Inc. 1020 East Meadow Circle Palo Alto CA 94303 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-08-13 | 20,000 | $5.11 | 274,760 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-08-13 | 1,655 | $136.49 | 273,105 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-08-13 | 3,489 | $137.52 | 269,616 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-08-13 | 3,281 | $138.40 | 266,335 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-08-13 | 11,575 | $139.45 | 254,760 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2015-08-13 | 20,000 | $0.00 | 20,000 | $5.11 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 4,000 | 2023-06-06 | No | 4 | M | Direct |
Footnotes
- Includes 1,000 shares purchased on July 31, 2015 pursuant to the Issuer's ESPP.
- This sale was effected pursuant to a pre-existing Rule 10b5-1 trading plan adopted by the reporting person for tax and estate planning purposes.
- The price reported in Column 4 is a weighted average price.
- These shares were sold in multiple transactions at prices ranging from $136.00 to $136.94, inclusive.
- These shares were sold in multiple transactions at prices ranging from $137.03 to $137.92, inclusive.
- These shares were sold in multiple transactions at prices ranging from $138.04 to $138.96, inclusive.
- These shares were sold in multiple transactions at prices ranging from $139.10 to $140.09, inclusive.
- This option is fully vested and exercisable.
Billionaire Hedge Funds
